Huntington disease The Huntington’s team is targeting early phases of HD, before the illness’s full impact takes its toll. Funding from Team KJ and patient advocates supported preliminary biosafety studies that enabled a successful CIRM grant submission. In the pipeline is exciting gene editing research that has the potential to treat the aggressive juvenile form of the disease (JHD). The JHD team is supported by a training grant from the National Institutes for Health, a generous donation from the Phyllis E. Dake Foundation, and other philanthropic contributions.

Please check out UC Davis' Huntington's disease Clinic.

Learn more about the UC Davis Huntington’s Disease Clinic »